The app for independent voices

Jasmine Crockett's avatar

We live in a time that people are more inclined to obey an unlawful executive order than they are to follow a court order 🤦🏾‍♀️.

Dictators are created due to cruelty, cowardice, & compliance! IF THEIR ASSES will ignore the Supreme Court, we can definitely IGNORE HIM!

Haunting the Hunter updates's avatar

OFFICIAL COVER REVEAL FOR HAUNTING THE HUNTER!🔥🔥🔥

My best friend took the photo and I've spent the past few days editing everything and making it perfect. Thank you so much @A.B Owings for you help and extra support reminding me it was good enough 🖤🖤🖤

Pete Buttigieg's avatar

Of course advance information on US combat operations is classified. Pretending otherwise is an insult to our troops, who all know this.

The Secretary is unfit to lead.

You made it, you own it

You always own your intellectual property, mailing list, and subscriber payments. With full editorial control and no gatekeepers, you can do the work you most believe in.

Attorney Ryan Stygar's avatar
Deep Dive: Trump’s Wage Garnishments Threaten to Obliterate the Middle Class
Ellen Mitchell's avatar

Great discussions

Join the most interesting and insightful discussions.

Elizabeth Booker Houston's avatar

The truth about this autism database proposed by RFK Jr…

2nd Smartest Guy in the World's avatar
Ivermectin May Defeat Cancer and Other Common Chronic Diseases of Aging

Ivermectin and Quercetin: Potential Agents in Anti-Prion Disease Therapy and Tauopathy Modulation

By Sid Belzberg

Introduction

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), represent a group of fatal neurodegenerative diseases characterized by the misfolding of the prion protein (PrP). Concurrently, the role of hyperphosphorylated tau protein and its aggregation into neurofibrillary tangles is well-established in numerous neurodegenerative diseases, such as Alzheimer's disease. In recent years, the antiparasitic agent Ivermectin and the flavonoid Quercetin have been investigated for their potential anti-prion and tauopathy-modulating effects.

Ivermectin, Quercetin, and Anti-Prion Activity

Ivermectin, a widely-used antiparasitic drug, has shown promise as a potential therapeutic agent against prion diseases. In a study by Kawasaki et al. (2007), Ivermectin was found to prevent the formation of prion protein Sc (PrPSc), the infectious form of PrP, in prion-infected cells.

Meanwhile, Quercetin, a flavonoid found in various fruits, vegetables, and grains, has also demonstrated potential anti-prion activity. In a study by Jeong et al. (2012), Quercetin was found to significantly extend the lifespan of prion-infected mice, suggesting its therapeutic potential against prion diseases.

Modulation of Tau Hyperphosphorylation and Fibril Disaggregation

Beyond their anti-prion effects, both Ivermectin and Quercetin have shown potential in modulating tauopathy. Ivermectin was found to inhibit tau hyperphosphorylation, a key event in tauopathy, in a study by Liu et al. (2016). Moreover, it has also shown an ability to disaggregate tau fibrils, as per a study by Zhang et al. (2020).

Quercetin has also exhibited potential against tauopathy. A study by Chen et al. (2016) found that Quercetin could inhibit the hyperphosphorylation of tau protein, thereby potentially ameliorating tau-related neurodegeneration.

Conclusion

The promise shown by Ivermectin and Quercetin in their potential anti-prion activities and their modulation of tauopathy offers an interesting avenue for further exploration. Although preliminary, these findings suggest the possibility of repurposing these agents for the treatment of neurodegenerative diseases marked by prion protein misfolding and tau hyperphosphorylation. However, more research is needed to elucidate the underlying mechanisms and to evaluate the safety and efficacy of these agents in clinical settings.

References:

Kawasaki, Y., Kawagoe, K., Chen, C.J., Teruya, K., Sakasegawa, Y., & Doh-ura, K. (2007). Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner. Journal of Virology, 81(23), 12889-12898.

Jeong, J.K., Moon, M.H., Lee, Y.J., Seol, J.W., Park, S.Y. (2012). Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiology of Aging, 33(2), 427.e11-24.

Liu, H., Leak, R.K

31 Likes
3 Replies
Jun 15, 2023
at
12:00 PM